2004
DOI: 10.1111/j.1525-1497.2004.40178.x
|View full text |Cite
|
Sign up to set email alerts
|

Utility of hemoglobin A1c in predicting diabetes risk

Abstract: BACKGROUND:There is controversy surrounding the issue of whether, and how, to screen adults for type 2 diabetes. Our objective was to measure the incidence of new diabetes among outpatients enrolled in a health care system, and to determine whether hemoglobin A1c (HbA1c) values would allow risk stratification for patients' likelihood of developing diabetes over 3 years.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

7
135
0
1

Year Published

2006
2006
2018
2018

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 182 publications
(143 citation statements)
references
References 31 publications
(28 reference statements)
7
135
0
1
Order By: Relevance
“…This is consistent with the contention by Kahn et al that clinical definitions of the metabolic syndrome are unnecessarily restrictive, and that the particular cluster of risk factors may not be as important as the assessment and management of each of them individually (50). Not included as often in this group of risk factors is A1c, which is emerging as a significant risk factor for diabetes, cardiovascular disease and cancer (51)(52)(53)(54)(55). In addition, there are suggestions that A1c should be used as a screening tool for diabetes in Aboriginal environments (56)(57)(58) and, thus, could be used as a first step in assessing the presence of diabetes and/or metabolic syndrome.…”
Section: Original Researchsupporting
confidence: 71%
“…This is consistent with the contention by Kahn et al that clinical definitions of the metabolic syndrome are unnecessarily restrictive, and that the particular cluster of risk factors may not be as important as the assessment and management of each of them individually (50). Not included as often in this group of risk factors is A1c, which is emerging as a significant risk factor for diabetes, cardiovascular disease and cancer (51)(52)(53)(54)(55). In addition, there are suggestions that A1c should be used as a screening tool for diabetes in Aboriginal environments (56)(57)(58) and, thus, could be used as a first step in assessing the presence of diabetes and/or metabolic syndrome.…”
Section: Original Researchsupporting
confidence: 71%
“…This is despite the many advantages to using HbA 1c over other glycaemic measures such as less intraindividual variation [29], good ability to detect undiagnosed diabetes [46,47] and predict risk of developing microvascular complications both in type 1 and type 2 diabetes [9,10,48], and widespread acceptance as a common endpoint in clinical trials. Our study suggests that HbA 1c may be a useful measure for diagnosing diabetes and supports a possible cut-off point at between 6.6% and 7.0%, which is in line with current recommendations [12,13,30,47].…”
Section: Discussionmentioning
confidence: 99%
“…found that diabetes incidence was 2.5% per year for HbA1c between 5.6% and 6.0% [21]. The Expert Committee defined individuals with an HbA1c between 6.0% and 6.5% as being at high risk of diabetes [11]; subsequently, in January 2010 a new threshold of 5.7% was published in the ADA recommendations [10].…”
Section: 7% 12/01/2012mentioning
confidence: 99%